Narcolepsy Therapeutics - Pipeline Assessment and

Market Forecasts to 2019

On 9thDecember 2014

Summary
The industry analysis specialist, has released its new report, Narcolepsy Therapeutics Pipeline Assessment and Market Forecasts to 2019. The report is an essential source of
information and analysis on the global Narcolepsy Therapeutics market. The report identifies
the key trends shaping and driving the global Narcolepsy Therapeutics market. The report also
provides insights on the prevalent competitive landscape and the emerging players expected to
significantly alter the market positioning of the current market leaders. Most importantly, the
report provides valuable insights on the pipeline products within the global Narcolepsy
Therapeutics sector. This report is built using data and information sourced from proprietary
databases, primary and secondary research and in-house analysis by GlobalDatas team of
industry experts.

You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-narcolepsy-therapeutics-pipeline-assessment-and-market-forecasts135222

Scope
The report provides information on the key drivers and challenges of the Narcolepsy
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Therapeutics market. Its scope includes - Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Narcolepsy
Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being
developed and emerging trends by seven key markets. Pipeline candidates fall under major
therapeutic classes.
- Analysis of the current and future competition in the seven key countries Narcolepsy
Therapeutics market.
- Insightful review of the key industry drivers, restraints and challenges. Each trend is
independently researched to provide a qualitative analysis of its implications.
- Key topics covered include strategic competitor assessment, market characterization, unmet
needs and the implications for the Narcolepsy Therapeutics market.
- Analysis of key recent licensing and partnership agreements in Narcolepsy Therapeutics
market

Reasons to buy
The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline
products and technologies and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global
Narcolepsy Therapeutics market.
- Drive revenues by understanding the key trends, innovative products and technologies,
market segments and companies likely to impact the global Narcolepsy Therapeutics market in
future.
- Formulate effective sales and marketing strategies by understanding the competitive
landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective
counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments
that present maximum opportunities for consolidations, investments and strategic
partnerships.
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

- Whats the next big thing in the global Narcolepsy Therapeutics market landscape? Identify,
understand and capitalize.

Other industries we cover:

Advertising and Media

Automotive and Parts
Consumer Goods
Healthcare and Medical
Finance and Banking
Food and Beverages
Travel and Tourism
Textiles and Clothing
SWOT Analysis

Discounts on Market Research Reports till 31st December, 2014

For more inquiries, contact at +91 - 998 729 5242 /
contact@jsbmarketresearch.com

Table of Content
2 Narcolepsy Therapeutics - Introduction
2.1 Disease Overview
2.1.1 Narcolepsy with Cataplexy
2.1.2 Narcolepsy without Cataplexy
2.2 Epidemiology
2.2.1 Prevalence
2.2.2 Quality of Life Parameters
2.3 Etiology and Pathophysiology
2.4 Signs and Symptoms
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

2.5 Diagnosis
2.5.1 Actigraphy
2.5.2 Multiple Sleep Latency Test (MSLT)
2.5.3 Polysomnography (PSG)
2.5.4 Hypocretin Test
2.6 Treatment and Management Options
2.6.1 Non-Pharmacological Treatment
2.6.2 Pharmacological Treatment
2.7 Referral Pathway
2.8 GlobalData Pipeline Report Guidance
3 NarcolepsyTherapeutics - Market Characterization
3.1 Overview
3.2 Narcolepsy Therapeutics Market Size (2006-2011) - Global
3.3 Narcolepsy Therapeutics Market Forecast (2011-2019) - Global
3.4 Narcolepsy Therapeutics Market Size (2006-2011) - The US
3.5 Narcolepsy Therapeutics Market Forecast (2011-2019) - The US
3.6 Narcolepsy Therapeutics Market Size (2006-2011) - France
3.7 Narcolepsy Therapeutics Market Forecast (2011-2019) - France
3.8 Narcolepsy Therapeutics Market Size (2006-2011) - Germany
3.9 Narcolepsy Therapeutics Market Forecast (2011-2019) - Germany
3.10 Narcolepsy Therapeutics Market Size (2006-2011) - Italy
3.11 Narcolepsy Therapeutics Market Forecast (2011-2019) - Italy
3.12 Narcolepsy Therapeutics Market Size (2006-2011) - Spain
3.13 Narcolepsy Therapeutics Market Forecast (2011-2019) - Spain
3.14 Narcolepsy Therapeutics Market Size (2006-2011) - The UK
3.15 Narcolepsy Therapeutics Market Forecast (2011-2019) - The UK
3.16 Narcolepsy Therapeutics Market Size (2006-2011) - Japan
3.17 Narcolepsy Therapeutics Market Forecast (2011-2019) - Japan
3.18 Drivers and Barriers for the Narcolepsy Therapeutics Market
3.18.1 Drivers for the Narcolepsy Therapeutics Market
3.18.2 Barriers for the Narcolepsy Therapeutics Market
3.19 Opportunity and Unmet Need Analysis
3.20 Key Takeaway
4 Narcolepsy Therapeutics - Competitive Assessment
4.1 Overview
4.2 Strategic Competitor Assessment
4.3 Product Profiles for the Major Marketed Products in the Narcolepsy Therapeutics Market
4.3.1 Provigil (modafinil)
4.3.2 Nuvigil (armodafinil)
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

4.3.3 Xyrem (sodium oxybate)

4.4 Key Takeaway
5 Narcolepsy Therapeutics - Pipeline Assessment
5.1 Overview
5.2 Strategic Pipeline Assessment
5.3 Narcolepsy Therapeutics Pipeline - Pipeline by Phases of Development
5.3.1 Narcolepsy Therapeutics - Phase III Pipeline
5.3.2 Narcolepsy Therapeutics - Phase II Pipeline
5.3.3 Narcolepsy Therapeutics - Pre-Clinical Pipeline
5.3.4 Narcolepsy Therapeutics -Discovery Pipeline
5.3.5 Technology Trends Analytic Framework
5.4 Narcolepsy Therapeutics Market - Pipeline by Mechanism of Action
5.5 Molecule Profile for Promising Drugs under Clinical Development
5.5.1 BF2.649 (pitolisant)
5.6 Key Takeaway
6 Narcolepsy Therapeutics - Clinical Trials Mapping
6.1 Clinical Trials by Region/Country (US, EU5 and Japan)
6.2 Clinical Trials by Phase
6.3 Clinical Trials by Trial Status
6.4 Prominent Sponsors
6.5 Top Companies Participating in Narcolepsy Therapeutics Clinical Trials
7 Narcolepsy Therapeutics - Strategic Assessment
7.1 Key Events Impacting the Future Market
7.2 Narcolepsy Therapeutics: Implications for Future Market Competition
8 Narcolepsy Therapeutics - Future Players
8.1 Introduction
8.2 Company Profiles
8.2.1 Bioprojet
8.2.2 Jazz Pharmaceuticals, Inc.
8.2.3 Teva Pharmaceuticals
9 Narcolepsy Therapeutics - Licensing and Partnership Deals
10 Narcolepsy Therapeutics - Appendix
10.1 Market Definitions
10.2 Abbreviations
10.3 Methodology
10.3.1 Coverage
10.3.2 Secondary Research
10.3.3 Forecasting
10.3.4 Primary Research
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

10.3.5 Expert Panel Validation

10.4 Contact Us
10.5 Disclaimer
10.6 Bibliography

List Of Tables
Table 1: Narcolepsy Therapeutics Market, Global, Revenue ($m), 2006-2011
Table 2: Narcolepsy Therapeutics Market, Global, Forecast ($m), 2011-2019
Table 3: Narcolepsy Therapeutics Market, Global, Revenue ($m), 2006-2011
Table 4: Narcolepsy Therapeutics Market, The US, Forecasts ($m), 2011-2019
Table 5: Narcolepsy Therapeutics Market, France, Revenue ($m), 2006-2011
Table 6: Narcolepsy Therapeutics Market, France, Forecasts ($m), 2011-2019
Table 7: Narcolepsy Therapeutics Market, Germany, Revenue ($m), 2006-2011
Table 8: Narcolepsy Therapeutics Market, Germany, Forecasts ($m), 2011-2019
Table 9: Narcolepsy Therapeutics Market, Italy, Revenue ($m), 2006-2011
Table 10: Narcolepsy Therapeutics Market, Italy, Forecasts ($m), 2011-2019
Table 11: Narcolepsy Therapeutics Market, Spain, Revenue ($m), 2006-2011
Table 12: Narcolepsy Therapeutics Market, Spain, Forecasts ($m), 2011-2019
Table 13: Narcolepsy Therapeutics Market, The UK, Revenue ($m), 2006-2011
Table 14: Narcolepsy Therapeutics Market, The UK, Forecasts ($m), 2011-2019
Table 15: Narcolepsy Therapeutics Market, Japan, Revenue ($m), 2006-2011
Table 16: Narcolepsy Therapeutics Market, Japan, Forecasts ($m), 2011-2019
Table 17: Average Sleep Latencies (In Minutes) on The MWT at Baseline for the Controlled Trials
Table 18: Percentages of Patients Who Showed Degree of Improvement on the CGI-C in the
Clinical Trials
Table 19: Average Baseline Sleep Latency and Change from Baseline at Final Visit (MWT and
MSLT in minutes)
Table 20: Clinical Global Impression of Change (CGI-C)
Table 21: Summary of Outcomes in Clinical Trials Supporting the Efficacy of Sodium Oxybate
Table 22: Clinical Global Impression of Change in Day and Nighttime Symptoms
Table 23: Narcolepsy Therapeutics - Phase III Pipeline, 2011
Table 24: Narcolepsy Therapeutics - Phase II Pipeline, 2011
Table 25: Narcolepsy Therapeutics - Pre-Clinical Pipeline, 2011
Table 26: Narcolepsy Therapeutics - Discovery Pipeline, 2011
Table 27: Narcolepsy Therapeutics - Clinical Trials by Country, 2011
Table 28: Narcolepsy Therapeutics - Clinical Trials by Phase, 2011
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Table 29: Narcolepsy Therapeutics - Clinical Trials by Status

Table 30: Narcolepsy Therapeutics - Prominent Sponsors, 2011
Table 31:Narcolepsy Therapeutics - Top Companies Participating in Therapeutics Clinical Trials,
2011
Table 32: Bioprojet - Pipeline for Narcolepsy, 2011
Table 33: Narcolepsy Therapeutics, Global, Deals, 2009-2011

List Of Figures
Figure 1: Pharmacological Treatment of Narcolepsy
Figure 2: Referral Pathway for Narcolepsy
Figure 3: Narcolepsy Therapeutics Market, Global, Revenue ($m), 2006-2011
Figure 4: Narcolepsy Therapeutics Market, Global, Forecast ($m), 2011-2019
Figure 5: Narcolepsy Therapeutics Market, the US, Revenue ($m), 2006-2011
Figure 6: Narcolepsy Therapeutics Market, The US, Forecast ($m), 2011-2019
Figure 7: Narcolepsy Therapeutics Market, France, Revenue ($m), 2006-2011
Figure 8: Narcolepsy Therapeutics Market, France, Forecast ($m), 2011-2019
Figure 9: Narcolepsy Therapeutics Market, Germany, Revenue ($m), 2006-2011
Figure 10: Narcolepsy Therapeutics Market, Germany, Forecast ($m), 2011-2019
Figure 11: Narcolepsy Therapeutics Market, Italy, Revenue ($m), 2006-2011
Figure 12: Narcolepsy Therapeutics Market, Italy, Forecast ($m), 2011-2019
Figure 13: Narcolepsy Therapeutics Market, Spain, Revenue ($m), 2006-2011
Figure 14: Narcolepsy Therapeutics Market, Spain, Forecast ($m), 2011-2019
Figure 15: Narcolepsy Therapeutics Market, The UK, Revenue ($m), 2006-2011
Figure 16: Narcolepsy Therapeutics Market, The UK, Forecast ($m), 2011-2019
Figure 17: Narcolepsy Therapeutics Market, Japan, Revenue ($m), 2006-2011
Figure 18: Narcolepsy Therapeutics Market, Japan, Forecast ($m), 2011-2019
Figure 19: Opportunity and Unmet Need for EDS in the Narcolepsy Therapeutics Market
Figure 20: Opportunity and Unmet Need for Cataplexy in the Narcolepsy Therapeutics Market
Figure 21: Narcolepsy Therapeutics - Strategic Competitor Assessment, 2011
Figure 22: Narcolepsy Therapeutics - Pipeline by Phase of Development, 2011
Figure 23: Narcolepsy Therapeutics - Technology Trends Analytics Framework, 2011
Figure 24: Narcolepsy Therapeutics - Technology Trends Analytics Framework - Description,
2011
Figure 25: Narcolepsy Therapeutics - Pipeline by Mechanism of Action, 2011
Figure 26: Clinical Trial Details of BF2.649 (pitolisant)
Figure 27: Narcolepsy Therapeutics - Clinical Trials by Country, 2011
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Figure 28: Narcolepsy Therapeutics - Clinical Trials by Phase, 2011

Figure 29: Narcolepsy Therapeutics - Clinical Trials by Status, 2011
Figure 30: Narcolepsy Therapeutics - Overall Sponsors, 2011
Figure 31: Narcolepsy Therapeutics - Prominent Sponsors, 2011
Figure 32: Narcolepsy Therapeutics - Top Companies Participating in Therapeutics Clinical Trials,
2011
Figure 33: Narcolepsy Therapeutics Market, Drivers and Restraints 2011
Figure 34: Implications for Future Market Competition in the Narcolepsy Market, 2011
Figure 35: Narcolepsy Therapeutics Market - Pipeline by Company, 2011
Figure 36: GlobalData Market Forecasting Model

Report Price:
Licence Type

Price

PDF

$ 3995

Site Licence

$ 7990

Enterprise Wide Licence

$ 11985

Related Reports:
Acute Spinal Cord Injury (ASCI) Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Amnesia Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Cancer Vaccines - Pipeline Assessment and Market Forecasts to 2018
Peptic Ulcer Therapeutics- Pipeline Assessment and Market Forecasts to 2018
Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Hepatic Encephalopathy - Pipeline Assessment and Market Forecasts to 2019
Diabetic Gastroparesis Therapeutics - Pipeline Assessment and Market Forecasts to 2019
Email ID- contact@jsbmarketresearch.com
Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/

Pancreatitis Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Paroxysmal Nocturnal Hemoglobinuria (PNH) Therapeutics - Pipeline Assessment and Market
Forecasts to 2019
Aplastic Anemia Therapeutics - Pipeline Assessment and Market Forecasts to 2019

You can order this report by calling on +91 - 998 7295 242 or mail us
your contact details at contact@jsbmarketresearch.com

About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along
with providing in-depth analysis though reports, JSB market research also provides regular
updates of the market though newsletters. Our reports are a well-researched work of market
researchers with an extensive knowledge and a good level of market experience.

To know more on Narcolepsy Therapeutics - Pipeline Assessment and Market

Forecasts to 2019
http://www.jsbmarketresearch.com/healthcare-medical/r-narcolepsytherapeutics-pipeline-assessment-and-market-forecasts-135222

Email ID- contact@jsbmarketresearch.com

Tel No- 91 2241236650
Published by- http:/www.jsbmarketresearch.com/